Here are the top stories from the last week:

Industry Updates

FTC Halts Action Against PBMs Accused of Plan that Raised Insulin Prices
The Federal Trade Commission has paused its action against pharmacy benefit managers accused of a scheme that increased insulin prices, with a stay in place for at least 105 days. Read more »

Digital Tools Play Important Role in Patient Experience, CVS Health Rx Report Finds
CVS Health's report highlights the importance of digital tools in pharmacy care, emphasizing the need for human interaction alongside technology. Read more »

DSN, Canadian Pharmacists Association Hold Groundbreaking Event in Toronto
Retail pharmacy leaders from the U.S. and Canada gathered in Toronto to discuss industry issues. The event highlighted differences in practice authority between the two countries and explored healthcare innovations led by pharmacists. Read more »

Study: Prevalence of Micronutrient Deficiencies in Patients with Type 2 Diabetes
This study highlights the role pharmacists can play in addressing micronutrient deficiencies in patients with type 2 diabetes, who are at a higher risk. Read more »

NACDS Congratulates Dr. Mehmet Oz on Confirmation as CMS Administrator
The National Association of Chain Drug Stores (NACDS) congratulates Dr. Mehmet Oz on his confirmation as the CMS administrator and calls for swift action on PBM reform legislation to ensure healthcare affordability and accessibility. Read more »

GoodRx Rolls Out New E-Commerce Experience for Retail Pharmacies
GoodRx has introduced a new e-commerce platform for retail pharmacies, starting with the Midwest-based supermarket chain Hy-Vee. Read more »

AAM Issues Statement on FDA Job Cuts
The Association for Accessible Medicines (AAM) has expressed concerns that recent FDA staff reductions could impact the approval and safety of generic and biosimilar medicines. Read more »

Massive Layoffs at Health Agencies Begin
Significant layoffs and restructuring at health agencies have raised concerns about their future capacity to handle public health crises and regulate medical products. Read more »

Cardinal Health Completes Acquisition of Advanced Diabetes Supply Group
Cardinal Health has finalized its acquisition of the Advanced Diabetes Supply Group, enhancing its growth strategy for at-home solutions. Read more »

Drug Updates

Meitheal Introduces Two New Generics
Meitheal Pharmaceuticals launched generic versions of Prostin VR and Victoza, offering safer alternatives and addressing product shortages. Read more »

Aveva Drug Delivery Systems Obtains FDA OK for Generic Lidocaine Patch
Aveva received FDA approval for its generic lidocaine patch, offering targeted pain relief and non-invasive treatment for post-herpetic neuralgia. Read more »

Glenmark Launches Vancomycin Hydrochloride for Injection
Glenmark introduced vancomycin hydrochloride for injection, expanding its institutional portfolio with a generic version of Mylan's product. Read more »

Amneal Launches Boruzu for Multiple Myeloma & Mantle Cell Lymphoma
Amneal recently debuted Boruzu, a ready-to-use oncology product for multiple myeloma and mantle cell lymphoma, streamlining pharmacy preparation steps. Read more »

Organon Expands Portfolio with Biosimilar Tocilizumab-bavi for Arthritis and COVID-19
Tocilizumab-bavi has received FDA approval as the first biosimilar to tocilizumab for treating various arthritis conditions in adults and children. Read more »»